Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Plos One|September 9, 2014
EGFR-targeted TRAIL and a Smac mimetic synergize to overcome apoptosis resistance in KRAS mutant colorectal cancer cellsYvonne Möller, Martin Siegemund, Sven Beyes, et al.
Plos One|November 21, 2012
Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimeticFederica Cossu, Mario Milani, Patrice Vachette, et al.
Radiation Research|July 11, 2002
Detection of ATM gene mutation in human glioma cell line M059J by a rapid frameshift/stop codon assay in yeastRika Tsuchida, Takayuki Yamada, Masatoshi Takagi, et al.
Plos One|December 3, 2010
Long-term survival of human neural stem cells in the ischemic rat brain upon transient immunosuppressionLaura Rota Nodari, Daniela Ferrari, Fabrizio Giani, et al.
Scientific Reports|December 18, 2015
SMC1B is present in mammalian somatic cells and interacts with mitotic cohesin proteinsLinda Mannini, Francesco Cucco, Valentina Quarantotti, et al.
Frontiers in Cellular Neuroscience|October 11, 2013
Comparative neuronal differentiation of self-renewing neural progenitor cell lines obtained from human induced pluripotent stem cellsChiara Verpelli, Luigi Carlessi, Giulia Bechi, et al.
DNA Repair|October 16, 2010
A novel defect in mitochondrial p53 accumulation following DNA damage confers apoptosis resistance in Ataxia Telangiectasia and Nijmegen Breakage Syndrome T-cellsValentina Turinetto, Paola Porcedda, Valentina Minieri, et al.
Cancer Science|February 23, 2005
Ataxia-telangiectasia-mutated dependent phosphorylation of Artemis in response to DNA damageLing Chen, Tomohiro Morio, Yoshiyuki Minegishi, et al.
Investigational New Drugs|July 9, 2010
Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosisFederica Servida, Daniele Lecis, Cinzia Scavullo, et al.
Oncotarget|June 2, 2015
Oncogenic KRAS sensitizes premalignant, but not malignant cells, to Noxa-dependent apoptosis through the activation of the MEK/ERK pathwayAnnalisa Conti, Maria Teresa Majorini, Richard Elliott, et al.
Pageof 8